Our Stroke portfolio delivers life-saving interventional solutions for patients with ischemic stroke for the best chance of a full recovery.
Our Vascular portfolio is transforming thrombectomy care for people suffering from devastating vascular diseases, including venous thromboembolism and acute limb ischemia.
We are developing the Telos robotic platform* to expand access to lifesaving care through purposeful design and innovation.
*Currently in development. Not approved for use or available for sale.
Imperative Care is addressing gaps across the entire patient journey to elevate care for patients suffering from stroke and other devastating vascular diseases.
Back to News
June 8, 2023
Imperative Care Announces Positive New Data Demonstrating Benefits of Zoom RDL, the First Stroke-Specific Radial Access Platform for Mechanical Thrombectomy
June 6, 2023
Imperative Care Appoints Shacey Petrovic to Board of Directors
April 3, 2023
Imperative Care Appoints Ariel Sutton to General Manager of Stroke Business
February 7, 2023
Imperative Care Announces Formation of Stroke Recovery Digital Health Company Kandu Health
January 4, 2023
Imperative Care Announces FDA Clearance and Initial Cases of Zoom RDL, the First Stroke-Specific Radial Access Platform for Mechanical Thrombectomy
Media Contact
Rigo Magana
Corporate Communications
rmagana@imperativecare.com
Investor Contact
Phil Nalbone
VP of Corporate Development and Investor Relations
pnalbone@imperativecare.com
Contact us
